A Low Incidence of Nontuberculous Mycobacterial Infections in Pediatric Hematopoietic Stem Cell Transplantation Recipients

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 11, 2006, Pages 1188-1197

  Unal, Elif ^a   Yen, Catherine ^a   Saiman, Lisa ^a   George, Diane ^a   Della Latta, Phyllis ^a   van de Ven, Carmella ^a   Morris, Erin ^a   Bradley, M Brigid ^a   Del Toro, Gustavo ^a   Garvin, James ^a   Bhatia, Monica ^a   Schwartz, Joseph ^a   Satwani, Prakash ^a   Roman, Elizabeth ^a   Cooney, Erin ^a   Wolownik, Karen ^a   Hawks, Ria ^a   Foley, Sandra ^a   Cairo, Mitchell S ^a  

^a Columbia University ^*  (United States)

Author keywords

Alemtuzumab; Atypical mycobacteria; Nontuberculous mycobacteria; Pediatric; Transplant

Indexed keywords

ALEMTUZUMAB; AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; ANTIVIRUS AGENT; AZITHROMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN; DOXYCYCLINE; ETHAMBUTOL; GATIFLOXACIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIFABUTIN; RIFAMPICIN; SULFAMETHOXAZOLE; THYMOCYTE ANTIBODY; TOBRAMYCIN; TSUKUBAENOLIDE; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC SENSITIVITY; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIUM CULTURE; BETA THALASSEMIA; CASE REPORT; CATHETER INFECTION; CHILD; CHILD CARE; CHOROID PLEXUS TUMOR; CHRONIC MYELOID LEUKEMIA; COMBINED IMMUNODEFICIENCY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EARLY DIAGNOSIS; EPENDYMOMA; FANCONI ANEMIA; FEMALE; FUNGUS; GRAFT VERSUS HOST REACTION; HEALTH CARE ORGANIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HISTIOCYTOSIS X; HODGKIN DISEASE; HUMAN; HURLER SYNDROME; INCIDENCE; MALE; MEDICAL RESEARCH; MEDULLOBLASTOMA; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; RECIPIENT; RESPIRATORY TRACT INFECTION; RHABDOMYOSARCOMA; RISK FACTOR; SICKLE CELL ANEMIA; SKIN INFECTION; SURVIVAL RATE; TIME; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES;

EID: 33750534415     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.07.006     Document Type: Article

References (31)

1. Gaviria J.M., Garcia P.J., Garrido S.M., Corey L., and Boeckh M. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 6 (2000) 361-369
2. Weinstock D.M., Feinstein M.B., Sepkowitz K.A., and Jakubowski A. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 31 (2003) 1015-1021
3. Roy V., and Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 19 (1997) 467-470
4. Cordonnier C., Martino R., Trabasso P., et al. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis 38 (2004) 1229-1236
5. Brown-Elliott B.A., Griffith D.E., and Wallace Jr. R.J. Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am 16 (2002) 187-220
6. Wagner D., and Young L.S. Nontuberculous mycobacterial infections: a clinical review. Infection 32 (2004) 257-270
7. Reichenbach J., Rosenzweig S., Doffinger R., Dupuis S., Holland S.M., and Casanova J.L. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 1 (2001) 503-511
8. Levendoglu-Tugal O., Munoz J., Brudnicki A., Fevzi Ozkaynak M., Sandoval C., and Jayabose S. Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis 27 (1998) 1227-1230
9. White M.H., Papadopoulos E.B., Small T.N., Kiehn T.E., and Armstrong D. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation 60 (1995) 957-960
10. Jacobson K.L., Teira R., Libshitz H.I., et al. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30 (2000) 965-969
11. Kurzrock R., Zander A., Vellekoop L., Kanojia M., Luna M., and Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 77 (1984) 35-40
12. Shah M.K., Sebti A., Kiehn T.E., Massarella S.A., and Sepkowitz K.A. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 33 (2001) 330-337
13. Doucette K., and Fishman J.A. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38 (2004) 1428-1439
14. Patel R., Roberts G.D., Keating M.R., and Paya C.V. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 19 (1994) 263-273
15. Hermida G., Richard C., Baro J., et al. Allogeneic BMT in a patient with CML and prior disseminated infection by mycobacterium avium complex. Bone Marrow Transplant 16 (1995) 183-185
16. Au W.Y., Cheng V.C., Ho P.L., et al. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transplant 32 (2003) 709-714
17. Mohite U., Das M., Saikia T., et al. Mycobacterial pulmonary infection post allogeneic bone marrow transplantation. Leuk Lymphoma 40 (2001) 675-678
18. Bradley M.B., and Cairo M.S. Cord blood immunology and stem cell transplantation. Hum Immunol 66 (2005) 431-446
19. Osunkwo I., Bessmertny O., Harrison L., et al. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 10 (2004) 246-258
20. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
21. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
22. Roman E., Osunkwo I., Militano O., et al. Liposomal amphotericin B (AMB)prophylaxis is effective in prevention of invasive mold infections (IMI) following allogeneic stem cell transplantation in pediatric recipients. Pediatr Blood Cancer 45 (2005) 137
23. Shereck E.B., Bessmertny O., Cooney E.M., et al. Cytomegalovirus (CMV) prophylaxis with alternate day ganciclovir/foscarnet in at risk pediatric allogeneic stem cell transplant (AlloSCT) recipients is 100% effective in preventing CMV infections and reducing ganciclovir hematopoietic toxicity. Blood 100 (2002) 2470
24. Militano O., Boskoff B., Del Toro G., et al. Sequential administration of sargramostim (GM-CSF) and filgrastim (G-CSF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients undergoing myeloablative (MA) conditioning: cost-effective and more rapid platelet recovery in UCB recipients. Biol Blood Marrow Transplant 12 (2006) Abstract 116
25. Pfyffer G. Mycobacterium: General characteristics, isolation and straining procedures. In: Murray P., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 8th ed Volume 1 (2003), ASM Press, Washington, DC 532-559
26. Nicholson O., Feja K., Larussa P., et al. Nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplant recipients: case report and review of the literature. Pediatr Infect Dis J 25 (2006) 263-267
27. Hale G., Xia M.Q., Tighe H.P., Dyer M.J., and Waldmann H. The CAMPATH-1 antigen (CDw52). Tissue Antigens 35 (1990) 118-127
28. Flynn J.M., and Byrd J.C. Campath-1H monoclonal antibody therapy. Curr Opin Oncol 12 (2000) 574-581
29. Willemze R., Richel D.J., Falkenburg J.H., et al. In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation. Bone Marrow Transplant 9 (1992) 255-261
30. Weinblatt M.E., Maddison P.J., Bulpitt K.J., et al. CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. Arthritis Rheum 38 (1995) 1589-1594
31. Abad S., Gyan E., Moachon L., et al. Tuberculosis due to Mycobacterium bovis after alemtuzumab administration. Clin Infect Dis 37 (2003) e27-e28